Leading Expert On U.S. Health Reform Gives His Two Cents
Paul Keckley noted that things may get worse before they get better in the healthcare and lifescience industry in the United States.
Blog
CEO Interview: Michael Moe On GSV Capital, A New Vehicle To Finance Growth Companies
GSV Capital Founder & CEO Michael Moe interviewed by OneMedRadio. GSV raised $50 million in an IPO in May 2011 to invest in emerging technology companies.
Novartis’ NVA237 improves lung function in pulmonary disease patients
Swiss drug maker Novartis said results from a phase three study remarkably improved lung function in a similar way to a rival drug.
Clinical Trials Managed in “The Cloud?”
The fundamental concept of cloud computing dates back to the 1960s, when John McCarthy was quoted as saying “computation may someday be organized as public utility.”
Protected: OneMedRadio: The JOBS Act — Promises and Pitfalls
There is no excerpt because this is a protected post.
Critical Sales and Distribution Considerations for the Buyer, Investor and Seller
For many emerging companies, one of their largest financial investments and most important strategic decisions is their approach to sales and distribution.
CEO Interview: Larry Birch Discusses DataTRAK Collaboration and Patent Suit
After bringing his clinical research software company back from near bankruptcy to steady profitability in 2010, CEO Larry Birch is going on the offensive.
e-Zassi To Present Solution To Fractured Medical Device Ecosystem
e-Zassi is the medical device industry’s first subscription-based, decision support software and technology marketplace.
Rib-X Pharmaceuticals’ Nobel Prize Winning Platform Combats Serious Infections
The antibiotic market is expected to reach $45 billion by 2012 driven by the deficiencies of currently available antibiotics.
Small Bone Innovations Addresses Unmet Needs in Joint Replacement
Orthopedic companies have focused on developing devices for large bone trauma, leaving the small bone and joint field lacking.